Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Bioremediation of Produced Water by a Polyextremophilic, Heavy-Metal-Resistant <em>Modicisalibacter</em> sp. Strain Wilcox

2 months 1 week ago
Produced water (PW), generated during oil and gas extraction, is a complex wastewater characterized by high salinity, hydrocarbons, and heavy metals, making treatment and beneficial reuse challenging. Bioremediation offers a sustainable treatment alternative, but the extreme physicochemical conditions of PW inhibit the growth and activity of most conventional microorganisms. This study evaluates the bioremediation potential and heavy metal tolerance mechanisms of the halophile, Modicisalibacter...
Damilare Ajagbe

CLO26-081: Extracellular Vesicle-Derived Tissue Factor as a Biomarker for Cancer-Associated Thrombosis: A Systematic Review

2 months 1 week ago
No abstract
Ujjwal Soni

Development of a Competency Based Curriculum for Advanced Practice Providers in Allergy &amp; Immunology

2 months 1 week ago
CONCLUSIONS: Competencies developed will inform individual lectures/modules in a Core Curriculum for APPs in A&I, a steppingstone in education dedicated to the APP role in the field.
Maureen Bauer

EPR26-189: Demographics, Comorbidities, and Mortality in Patients With Hematologic Malignancies With and Without HIV: An NIH-Based Comparative Analysis

2 months 1 week ago
No abstract
Madhu Bhargavi Chandra

Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple Sclerosis

2 months 1 week ago
BACKGROUND AND OBJECTIVES: Oral cladribine tablet (CladT) therapy is efficacious for relapsing multiple sclerosis (MS). However, the mechanisms by which cladribine exerts benefit in MS remain unclear, particularly regarding its effects on compartmentalized inflammation within the CSF.
Roman A Smirnov

Pagination

  • Previous page ‹ Previous
  • Page 80
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies